Table 2 Chemotherapy regimens

SCLC

n = 9

 CDDP/CBDCA + VP-16

4

 NGT

2

 AMR

3

NSCLC (EGFR mutation wild type)

n = 22

 CBDCA + PAC + BEV

2

 CBDCA + PAC

4

 CBDCA + nab-PAC

1

 CDDP/CBDCA + PEM

7

 PEM

3

 DOC

5

NSCLC (EGFR mutation sensitive)

n = 5

 gefitinib

2

 erlotinib

3